Back

Optimal dual antiplatelet treatment (DAPT) duration following drug eluting stent with bioabsorbable polymer and abluminal coating, NIPPON study .

29 August 2016 (10:10 - 10:50)
Organised by:
Congress Presentation Part of: Meet the Trialist II - Optimal dual antiplatelet treatment (DAPT) duration following drug eluting stent with bioabsorbable polymer and abluminal coating, NIPPON study . Medical treatment ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Masato Nakamura

Toho University, Tokyo (Japan)

Access the full session

Session thumbnail
Meet the Trialist II - Optimal dual antiplatelet treatment (DAPT) duration following drug eluting stent with bioabsorbable polymer and abluminal coating, NIPPON study .

The Event

Event poster

ESC Congress 2016

29 August 2016 10:10 CET
You may be interested in
thumbnail
Congress Presentation
One-month dual antiplatelet therapy following stent implantation in patients with acute coronary syndromes and high bleeding risk
27 August 2023
thumbnail
Congress Presentation
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
27 August 2023
thumbnail
Congress Presentation
Optimal strategy for antiplatelet therapy after coronary drug-eluting stent implantation in high-risk "TWILIGHT-like" patients with diabetes mellitus
17 April 2021
thumbnail
Congress Presentation
Efficacy and safety of P2Y12 inhibitors plus aspirin versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources